Advisory Research’s LivaNova LIVN Stock Holding History

Advisory Research’s Portfolio LIVN Stock Details LIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-22,032	Closed	-$2.14M	–	379
2019 Q1	$2.14M	Buy	22,032 +7,319	+50%	+$683K	0.04%	179
2018 Q4	$1.35M	Buy	+14,713	New	+$1.58M	0.03%	207

Other funds holding LIVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advisory Research's LIVN Position: Q2 2019 in Review

Advisory Research sold out of LivaNova (LIVN) in Q2 2019, closing a stake of 22,032 shares — an estimated $2.14M sold.

Advisory Research first reported a position in LIVN in Q4 2018 and held it in 2 quarters. The position peaked at $2.14M in Q1 2019. 214 funds tracked by Wall St. Rank hold LIVN as of Q2 2019.

Advisory Research reported no remaining LivaNova position as of Q2 2019 after selling out during the quarter.
Advisory Research sold 22,032 LivaNova shares in Q2 2019, an estimated $2.14M.
Advisory Research first reported a position in LivaNova in Q4 2018 and held it in 2 quarters.
Advisory Research's LivaNova position peaked at $2.14M in Q1 2019.
214 funds tracked by Wall St. Rank held LivaNova as of Q2 2019.

Based on Advisory Research's 13F filing for Q2 2019, filed 14 Aug 2019.